Page last updated: 2024-11-04

2-amino-2-methyl-1,3-propandiol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-amino-2-methylpropane-1,3-diol : An aminodiol that is propane-1,3-diol substituted ny an amino and a methyl group at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID1531
CHEBI ID991
SCHEMBL ID23687
MeSH IDM0071569

Synonyms (63)

Synonym
1,1-di(hydroxymethyl)ethylamine
nsc6364
nsc-6364
aminoglycol
1, 2-amino-2-methyl-
wln: q1xz1 & 1q
isobutandiol-2-amine
2-amino-2-methyl-1,3-propanediol
ampd
2-amino-2-methylpropane-1,3-diol
CHEBI:991
ai3-03949
nsc 6364
brn 0635708
1,3-propanediol, 2-amino-2-methyl-
einecs 204-100-7
aminomethyl propanediol
2-amino-2-methyl-1,3-propandiol
115-69-5
2-amino-2-methyl-1,3-propanediol, bioxtra, ph 10.0-12.0 (20 c, 0.5 m in h2o), >=99%
2-amino-2-methyl-1,3-propanediol, >=99%
95E0210B-CCBA-4485-9DA0-34844FF88E42
A0332
uxfqfbnbspqbjw-uhfffaoysa-
inchi=1/c4h11no2/c1-4(5,2-6)3-7/h6-7h,2-3,5h2,1h3
AKOS006222995
cz7bu4qzjz ,
4-04-00-01881 (beilstein handbook reference)
unii-cz7bu4qzjz
FT-0611017
STL373468
aminomethyl propanediol [inci]
2-amino-2-methyl-1,3-propanediol [mi]
2-methyl-2-amino-1,3-propanediol
1,3-dihydroxy-2-methyl-2-propylamine
ammediol
2-amino-2-methylpropan-1,3-diol
amediol
1,3-dihydroxy-2-amino-2-methylpropane
BBL027473
SCHEMBL23687
2-hydroxymethyl-2-amino-1-propanol
1,3-dihydroxy-2-methyl-2-amino-propane
2-amino-2-methyl-1-3-propandiol
2-amino-2-methylpropane 1,3-diol
2-amino-2-methylpropane-1,3diol
2-amino-2-methyl-propane-1,3-diol
2-amino-2-methyl-1,3propanediol
DTXSID7059430
mfcd00004678
J-003318
F2190-0374
2-amino-2-methyl-1,3-propanediol, >=97.0% (gc)
2-amino-2-methyl-1,3-propanediol, bioultra, >=99.5% (nt)
AT27658
Q3598002
VS-08545
AMY14265
SB83841
EN300-93582
HY-W017054
CS-W017770
SY011284

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The Cosmetic Ingredient Review Expert Panel concludes that aminomethyl propanol and aminomethyl propanediol are safe as cosmetic ingredients in the practices of use and concentrations as described in this safety assessment."( Final amended report on safety assessment on aminomethyl propanol and aminomethyl propanediol.
Andersen, FA; Belsito, DV; Bergfeld, WF; Burnett, CL; Klaassen, CD; Marks, JG; Shank, RC; Slaga, TJ; Snyder, PW,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aminodiolAn amino alcohol having two hydroxy functional groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (26.67)18.7374
1990's4 (26.67)18.2507
2000's5 (33.33)29.6817
2010's2 (13.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.74 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]